Literature DB >> 20697980

Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS).

Micheline McCarthy1, Avindra Nath.   

Abstract

Although major advancements have been made in the treatment of HIV infection, graft-versus-host reactions, and autoimmune diseases, an unexpected consequence of treatment has been the emergence of a devastating inflammatory syndrome, termed the immune reconstitution inflammatory syndrome (IRIS). The pathophysiology of the syndrome is poorly understood, and the syndrome poses unique challenges for diagnosis and treatment. We have reviewed the neurologic manifestations of IRIS in the context of HIV infection as well as in the setting of treatment of autoimmune diseases such as multiple sclerosis, in which compartmental immune suppression may occur without an obvious underlying immune suppression. The purpose of this review is to identify common themes that may assist in the diagnosis and management of these IRIS syndromes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697980      PMCID: PMC9295338          DOI: 10.1007/s11910-010-0138-y

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   6.030


  46 in total

Review 1.  Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome.

Authors:  David J Riedel; Carlos A Pardo; Justin McArthur; Avindra Nath
Journal:  Nat Clin Pract Neurol       Date:  2006-10

2.  Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy.

Authors:  Luc Kestens; Nabila Seddiki; Paul R Bohjanen
Journal:  Curr Opin HIV AIDS       Date:  2008-07       Impact factor: 4.283

3.  Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

Authors:  Somnuek Sungkanuparph; Scott G Filler; Ploenchan Chetchotisakd; Peter G Pappas; Tracy L Nolen; Weerawat Manosuthi; Thanomsak Anekthananon; Michele I Morris; Khuanchai Supparatpinyo; Heather Kopetskie; Amy S Kendrick; Philip C Johnson; Jack D Sobel; Robert A Larsen
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

4.  Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases.

Authors:  Patricia Price; Grant Morahan; Dexing Huang; Emma Stone; Karey Y M Cheong; Alison Castley; Marina Rodgers; Meredith Q McIntyre; Lawrence J Abraham; Martyn A French
Journal:  AIDS       Date:  2002-10-18       Impact factor: 4.177

5.  Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study.

Authors:  Guy E Thwaites; Jeremy Macmullen-Price; Thi Hong Chau Tran; Phuong Mai Pham; Thi Dung Nguyen; Cameron P Simmons; Nicholas J White; Tinh Hien Tran; David Summers; Jeremy J Farrar
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

Review 6.  Antibiotic induced endotoxin release and clinical sepsis: a review.

Authors:  R G Holzheimer
Journal:  J Chemother       Date:  2001-11       Impact factor: 1.714

Review 7.  Tuberculous cerebrovascular disease: a review.

Authors:  G Alistair Lammie; Richard H Hewlett; Johan F Schoeman; Peter R Donald
Journal:  J Infect       Date:  2009-07-25       Impact factor: 6.072

Review 8.  Drug Insight: steroids in CNS infectious diseases--new indications for an old therapy.

Authors:  Michael T Fitch; Diederik van de Beek
Journal:  Nat Clin Pract Neurol       Date:  2008-02

9.  Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series.

Authors:  Dominique J Pepper; Suzaan Marais; Gary Maartens; Kevin Rebe; Chelsea Morroni; Molebogeng X Rangaka; Tolu Oni; Robert J Wilkinson; Graeme Meintjes
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

10.  Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.

Authors:  David M Murdoch; Willem D F Venter; Annelies Van Rie; Charles Feldman
Journal:  AIDS Res Ther       Date:  2007-05-08       Impact factor: 2.250

View more
  6 in total

1.  Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society.

Authors:  A Ghezzi; L M E Grimaldi; M G Marrosu; C Pozzilli; G Comi; A Bertolotto; M Trojano; P Gallo; R Capra; D Centonze; E Millefiorini; S Sotgiu; V Brescia Morra; M P Amato; A Lugaresi; G Mancardi; D Caputo; E Montanari; L Provinciali; L Durelli; R Bergamaschi; P Bellantonio; M R Tola; S Cottone; G Savettieri; G Tedeschi
Journal:  Neurol Sci       Date:  2011-04       Impact factor: 3.307

2.  Multiple sclerosis reactivation postfingolimod cessation: is it IRIS?

Authors:  R Alroughani; A Almulla; S Lamdhade; A Thussu
Journal:  BMJ Case Rep       Date:  2014-10-15

3.  Neurological complications of solid organ transplantation.

Authors:  Amy A Pruitt; Francesc Graus; Myrna R Rosenfeld
Journal:  Neurohospitalist       Date:  2013-07

Review 4.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 5.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

6.  Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study.

Authors:  Pria Anand; Gladia C Hotan; Andre Vogel; Nagagopal Venna; Farrah J Mateen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.